← All trials
NCT03697798
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 18, 2018
- Primary completion
- Feb 14, 2019
- Completion date
- Dec 31, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 122
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of OxfordLead sponsor
- University of TurkuOverall official - principal investigator
- National Institute for Public Health and the Environment, RIVM, HollandCollaborator
- University of OxfordOverall official - principal investigator
- University of TurkuCollaborator
- Spaarne GasthuisOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.